Merrick’s, Inc., a leading dairy industry supplier was acquired by Vets Plus, Inc., a leading manufacturer of health and nutrition products for livestock animals. The acquisition is expected to strengthen Vets Plus’s existing business through Merrick’s extensive portfolio.
Merrick’s assets were acquired by the new entity Merrick’s Animal Health, LLC. This new entity will be a subsidiary of Vets Plus, Inc. Merrick’s Animal Health business will continue its full line of products through its Wonewoc, WI’s manufacturing plant. At the company’s Middleton, WI office, operations of sales and customer services will continue. The company announced that employees of Merrick and their contact details remain unchanged after the acquisition.
Vets Plus’s president informed that Merrick’s animal health management team will be replaced by VPI’s senior management team. The Food Animal Sales’ director will continue to represent the new product line. The Wonewoc’s operations including nutrition and quality control will be led by Dan Shields like before.
The CEO of Vets Plus conveyed expansion of company’s offering through the acquisition. Addition of Merrick is expected to boost rapidly growing business of Vets Plus. The acquisition adds production and warehouse space of 66,000 square feet to the Wonewoc plant. This makes Vets Plus hold production and warehouse place of about 350,000 square feet.
As Merrick’s product portfolio complements Vets Plus’s business activities, the acquisition is expected to use both the company’s know-how in the industry to expand existing product portfolio with innovation as well as strengthen the customer relationship.
Vets Plus, Inc. is a leading producer of nutrition and health products for companion animals and livestock. The Menomonie-based company founded in 1990 carries its reputation as an innovation leader in the global industry of animal health. The company employs about 200 people at its Menomonie, Wisconsin campus.
For more information you can visit at https://www.factmr.com/report/380/vitamins-derivatives-market